A
AMPH
Amphastar Pharma
26.62
+0.81+3.14%After Hours: 26.62 0.00 0.00%19:30 10/09 EDT
OPEN/PREV CLOSE25.73/25.81
TODAY RANGE25.65-26.79
VOL437.70K
MARKET CAP1.13B
52 WEEK RANGE16.65-29.52
AVG VOL (3M)474.37K
% TURNOVER0.50%
TURNOVER--
P/E (TTM)15.57
% RANGE4.42%
EPS(TTM)1.710
P/E(FORWARD)12.27
P/B1.474
BVPS18.06
DIVIDEND--
P/S1.688
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP783.54M
SHARES OUTSTANDING42.54M
NEXT EARNINGS11/04-11/09
FREE FLOAT29.43M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·09/30 19:41
Amphastar: 2 Years Since My Last Hold Call, I Remain On The Sidelines
Simply Wall St·09/29 04:33
Amphastar Pharmaceuticals (AMPH) Rebounds On Momentum, Is The 20% Premium Already Too Rich?
Simply Wall St·09/18 21:24
Amphastar Pharmaceuticals (AMPH) Could Be 4% Above Fair Value After Its Q2 Beat
Seeking Alpha·09/17 18:21
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
Simply Wall St·09/05 10:20
Is Amphastar Pharmaceuticals (AMPH) Cheap After Its Recent Share Price Rebound?
TipRanks·09/02 15:05
Wells Fargo Sticks to Their Hold Rating for Amphastar Pharmaceuticals (AMPH)
NASDAQ·08/27 17:06
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
Benzinga·08/24 21:06
12 Health Care Stocks Moving In Monday's After-Market Session
TipRanks·08/21 00:19
Amphastar Pharmaceuticals Earnings Call Balances Growth And Risk
Dow Jones·08/18 18:10
Amphastar Pharmaceuticals Is Maintained at Equal-Weight by Barclays
TipRanks·08/18 15:15
Amphastar price target raised to $23 from $20 at Barclays
Simply Wall St·08/14 10:42
Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals
NASDAQ·08/14 08:06
New Strong Sell Stocks for August 14th